St. Jude Children’s Research Hospital scientists have created AI-powered M-PACT to facilitate next-generation classification of pediatric brain tumors by liquid biopsy.

Decreases in circulating tumor DNA (ctDNA) within the first month of immune checkpoint inhibitor (ICI) therapy were strongly ...

Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer's biology. However, technological ...

DNA from glove tied to Nancy Guthrie abduction shows no CODIS match as investigators pursue new leads. Follow live.

Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer's biology. However, technological ...

St. Jude Children’s Research Hospital scientists and multinational collaborators created AI-powered M-PACT to facilitate next ...

Liquid biopsy encompasses a variety of molecular approaches to detect circulating tumor DNA (ctDNA) and has become a powerful tool in the diagnosis and treatment of solid tumors. Current applications ...

Class A shares of the Alger Mid Cap Growth Fund outperformed the Russell Midcap Growth Index during the fourth quarter of ...

In an advance for precision oncology, the largest published study to date on molecular residual disease (MRD) detection in stage 3 colon cancer has demonstrated the prognostic capabilities of Guardant ...

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2025 Earnings Call Transcript February 17, 2026 NeoGenomics, Inc. misses on earnings ...

February 17, 2026) Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA ...

A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...